Neoadjuvant PD-1 Monoclonal Antibody Plus Cisplatin-based Chemotherapy in Locally Advanced Upper Tract Urothelial Carcinoma

NCT04672317 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Neoadjuvant Therapy of Locally Advanced Upper Urinary Tract Urothelial Carcinoma

Interventions

DRUG: Immunotherapy combined with chemotherapy

Sponsor

RenJi Hospital